Sir Tom Hunter, through West Coast Capital (WCC), the investment arm of the Hunter family, has made a multi-million-pound contribution to Ellipses Pharma, an innovative cancer drug venture.
St Andrews-based biotech firm Pneumagen has secured £8 million in financing from existing and new investors to support the continued Phase 2 development of Neumifil, a broad-spectrum antiviral, intranasal drug for the prophylaxis and treatment of viral respiratory tract infections (RTIs).
German science and technology giant, Merck, has announced plans to invest €35 million (£30m) in the expansion of its biosafety testing capabilities in Glasgow and Stirling.
Edinburgh-based Lentitek Ltd, a developer of pioneering manufacturing technologies enabling economic delivery of advanced cell and gene therapies, announced today that it has secured £250,000 ($300,000 USD) in seed investment. This investment will be deployed to further advance its technology and commence initial commercial trials.
The Sustainable Aquaculture Innovation Centre (SAIC) has announced support for a further six innovation projects valued at £2.5 million, taking its total investment in research and development initiatives to 100 projects.